Maria Τektonidou/LinkedIn
Apr 2, 2026, 14:39
Maria Τektonidou: STAT1 as a Potential Therapeutic Target in Thrombotic Antiphospholipid Syndrome
Maria Τektonidou, Professor of Rheumatology at National and Kapodistrian University of Athens, shared a post on LinkedIn, about a recent article she and her colleagues co-authored, adding:
“Gene co-expression and drug-gene interaction analysis reveal STAT1 as a potential therapeutic target in thrombotic antiphospholipid syndrome”
Title: RNA sequencing-derived gene co-expression and drug-gene interaction analysis reveal STAT1 as a potential therapeutic target in thrombotic antiphospholipid syndrome
Authors: Michail Baltsiotis, Kleio-Maria Verrou, Petros P Sfikakis, Maria G Tektonidou
Read the Full Article on Frontiers in Immunology
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 2, 2026, 14:55André da Silva: Stroke Is Not an Explosion – It’s Often a Silent Loss of Blood Flow
-
Apr 2, 2026, 14:18Deise Catamo Vaz: WSO Future Stroke Leaders Project Offers A Closing for Large Information Gap in PSCI
-
Apr 2, 2026, 14:18Abdul Mannan: Free Warfarin and Thrombosis Management Tool for Clinicians
-
Apr 2, 2026, 14:06Mike Sharma Named 2026 Hnatyshyn Lecturer for His Profound Impact on Stroke Care – Heart and Stroke
-
Apr 2, 2026, 13:53Ahvie Herskowitz: Therapeutic Plasma Exchange as a Precision Cancer Weapon
-
Apr 2, 2026, 13:51Clare Woodford: New NHS Access to Semaglutide Offers Hope to Prevent Another Stroke or Heart Attack
-
Apr 2, 2026, 13:46Ney Carter Borges: Plaque Erosion Defines a Distinct Mechanistic and Clinical Phenotype in Acute Coronary Syndrome
-
Apr 2, 2026, 13:19John Michael Quinn: Prehospital Whole Blood Remains Critical in Trauma Care
-
Apr 2, 2026, 13:04Dario Bongiovanni: ESC Working Group on Thrombosis Consensus Document Is Now Live